Volume 19, Issue 3
An Awareness of Pharmacovigilance among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy
Pp: 317-331
Author(s): Risani Andalasia Putri, Zullies Ikawati*, Fita Rahmawati and Nanang Munif Yasin
DOI: 10.2174/0115748863276456231016062628
Incidence and Severity of Adverse Drug Reactions in Medical Intensive Care Unit
Pp: 332-341
Author(s): Sana Shaikh, Asawari Raut*, Prajkta Jambhale, Shivkumar Iyer and Jignesh Shah
DOI: 10.2174/1574886318666230816090606
Interactions between Antimicrobial Peptides and Targets Responsible for their Nephrotoxic Action: Molecular Dynamics Simulations
Pp: 342-349
Author(s): Yury Lisnyak, Artur Martynov* and Boris Farber
DOI: 10.2174/1574886318666230905100924
Evaluation of High-dose versus Standard-dose of Dexamethasone on Mortality among the Mechanically Ventilated COVID-19 Patients
Pp: 350-355
Author(s): Pramodini B. Kale-Pradhan*, Regina Pacitto, Christopher A. Giuliano and Leonard B. Johnson
DOI: 10.2174/1574886318666230817102043
Chemotherapy-Induced Peripheral Neuropathy Impacts Quality of Life and Activities of Daily Living of Brazilian Multiple Myeloma Patients
Pp: 356-367
Author(s): Paula Lana de Miranda Drummond*, Roberta Márcia Marques dos Santos, Lívia Pena Silveira, Jéssica Soares Malta, Adriano Max Moreira Reis, Naiane Lima Costa, Roberta Oliveira de Paula e Silva, Evandro Maranhão Fagundes and Cristiane Aparecida Menezes de Pádua
DOI: 10.2174/1574886318666230817162424
Pharmacists’ Medication Reconciliation Interventions during Admission and Transfer from an Emergency Department at a Tertiary Care Hospital: A Randomized Pilot Study and Evaluation of Physician and Patient Perceptions
Pp: 368-376
Author(s): Ashitha George Joseph, Santra Saji, Anagha Nivrutti Kumbhar, Shivakumar G., Ramesh Bhandari* and M. S. Ganachari
DOI: 10.2174/1574886318666230911144912
Hepatitis E Virus in Individuals Undergoing Heparin Therapy: An Observational Serological and Molecular Study
Pp: 377-381
Author(s): João R. Mesquita*, Sérgio Santos-Silva, Nanci Ferreira, Antonio Rivero-Juarez, Guilherme Gonçalves and Maria São José Nascimento
DOI: 10.2174/0115748863272272231122114732
Assessment of Neurologic Safety Profile of Immune Checkpoint Inhibitors: Evaluation of Adverse Drug Reaction Reports
Pp: 382-394
Author(s): Atul Khurana, Harikesh Dubey and Mandeep Kumar Arora*
DOI: 10.2174/0115748863273507231116112824
Identification of Novel Signals Associated with US-FDA Approved Drugs (2013) Using Disproportionality Analysis
Pp: 395-401
Author(s): Sourabh Raghuvanshi, Mohammad Akhlaquer Rahman, Mahesh Kumar Posa and Anoop Kumar*
DOI: 10.2174/0115748863276447231108092936
Association of Cardiovascular Events with COVID-19 Vaccines Using Vaccine Adverse Event Reporting System (VAERS): A Retrospective Study
Pp: 402-406
Author(s): Mohd Amir, S. Latha, Ruchika Sharma and Anoop Kumar*
DOI: 10.2174/0115748863276904231108095255
